Protein metabolism during intensive physical training in the young adult. (17/304)

Two groups of men consumed two levels of protein (1.4 and 2.8 g/kg body weight) during a 40-day experimental period. Physical activity and the sweat rates were fairly high during the entire experimental phase. Urinary nitrogen excretions remained fairly constant for both groups during the training and heavy physical activity periods. Nitrogen balances were positive exclusive or inclusive of the daily sweat nitrogen losses showing nitrogen retention. The essentially unchanged blood hemoglobin and serum protein levels showed that the control group was receiving an adequate protein intake to maintain nitrogen equilibrium, under conditions of fairly heavy physical acitvity. Although others may have suggested some compensatory reductions in the urinary excretion of nitrogen under conditions of profuse sweating, our data have not supported these conclusions. It appears that sweat losses of nutrients become relevant in determining requirements and will increase in importance as sweat rates are increased. The data again demonstrate that the nutrient losses during profuse sweating consitute an error that could seriously invalidate the accuracy of metabolic balance studies. In this study, although the men did increase body protein stores and muscle mass with high-protein diets, the additional body protein did not enhance physiological work performance. It is suggested that in this sutdy 100 g of protein/day was adequate for men performing fairly heavy work.  (+info)

Variations in regional sweat composition in normal human males. (18/304)

This project aimed to quantify the regional distribution of sweat composition over the skin surface and to determine whether sweat constituent concentrations collected from regional sites can estimate whole-body concentrations. Ten males cycled for 90 min in a 20 degrees C (50% relative humidity) environment at 45% peak aerobic power. Sweat was collected from eleven skin regions and the whole body, using a wash-down technique. Strong relationships were evident between the regional and whole-body sweat [Na+] and [Cl-], such that the thigh and calf exhibited greater correlation coefficients than area-weighted means derived from four and eight skin regions. Therefore, in this particular protocol the whole-body sweat [Na+] and [Cl-] could be predicted from regional sweat collections. Relationships between sweat constituents were evident for sweat [Na+] and pH, and sweat [K+] and [lactate] when data were pooled between skin regions and subjects. To our knowledge this is the first investigation to report a positive relationship between sweat [K+] and [lactate]. The exact mechanism responsible for the positive relationship between sweat [K+] and [lactate] is uncertain although it is speculated to occur at the secretory coil.  (+info)

Na(+)/glutamine (asparagine) cotransport by Staphylococcus lugdunensis and Corynebacterium amycolatum. (19/304)

Staphylococcus lugdunensis and Corynebacterium amycolatum each have a Na(+)/glutamine cotransporter that displays an ordered reaction sequence at the extracellular surface, with sodium binding (K(m) of 6.5 mM) before glutamine (K(m) of 50 microM). Asparagine is low-affinity substrate (K(m) approximately 1 mM) for each system.  (+info)

In vivo confocal Raman microspectroscopy of the skin: noninvasive determination of molecular concentration profiles. (20/304)

Confocal Raman spectroscopy is introduced as a noninvasive in vivo optical method to measure molecular concentration profiles in the skin. It is shown how it can be applied to determine the water concentration in the stratum corneum as a function of distance to the skin surface, with a depth resolution of 5 microm. The resulting in vivo concentration profiles are in qualitative and quantitative agreement with published data, obtained by in vitro X-ray microanalysis of skin samples. Semi-quantitative concentration profiles were determined for the major constituents of natural moisturizing factor (serine, glycine, pyrrolidone-5-carboxylic acid, arginine, ornithine, citrulline, alanine, histidine, urocanic acid) and for the sweat constituents lactate and urea. A detailed description is given of the signal analysis methodology that enables the extraction of this information from the skin Raman spectra. No other noninvasive in vivo method exists that enables an analysis of skin molecular composition as a function of distance to the skin surface with similar detail and spatial resolution. Therefore, it may be expected that in vivo confocal Raman spectroscopy will find many applications in basic and applied dermatologic research.  (+info)

Function of human eccrine sweat glands during dynamic exercise and passive heat stress. (21/304)

The purpose of this study was to identify the pattern of change in the density of activated sweat glands (ASG) and sweat output per gland (SGO) during dynamic constant-workload exercise and passive heat stress. Eight male subjects (22.8 +/- 0.9 yr) exercised at a constant workload (117.5 +/- 4.8 W) and were also passively heated by lower-leg immersion into hot water of 42 degrees C under an ambient temperature of 25 degrees C and relative humidity of 50%. Esophageal temperature, mean skin temperature, sweating rate (SR), and heart rate were measured continuously during both trials. The number of ASG was determined every 4 min after the onset of sweating, whereas SGO was calculated by dividing SR by ASG. During both exercise and passive heating, SR increased abruptly during the first 8 min after onset of sweating, followed by a slower increase. Similarly for both protocols, the number of ASG increased rapidly during the first 8 min after the onset of sweating and then ceased to increase further (P > 0.05). Conversely, SGO increased linearly throughout both perturbations. Our results suggest that changes in forearm sweating rate rely on both ASG and SGO during the initial period of exercise and passive heating, whereas further increases in SR are dependent on increases in SGO.  (+info)

Sweat testing of MDMA with the Drugwipe analytical device: a controlled study with two volunteers. (22/304)

Rapid on-site tests for the analysis of drugs of abuse in unconventional specimens (e.g., sweat) have recently been developed. Two healthy volunteers familiar with the effects of methylenedioxymethamphetamine (MDMA) were given 100 mg of the drug as a single oral dose. MDMA and its main metabolite 4-hydroxy-3-methoxymethamphetamine (HMMA) were determined in plasma and urine by gas chromatography-mass spectrometry (GC-MS). MDMA was also investigated in sweat with the Drugwipe (an immunochemical strip test). Subjects' armpits were swabbed for 10 s at 0 time (predose) and at 2, 6, 8, 12, and 24 h after MDMA administration. MDMA consumption could be detected using Drugwipe at 2 h and for as long as 12 h after drug administration. However, in one of the volunteers, a faint color change appeared at 0 time, when plasma and urine tested negative for MDMA and did not disappear even 48 h later. Plasma concentrations of MDMA and HMMA measured by GC-MS peaked at 2-4 h, and values greater than 20 ng/mL for MDMA and of 40 ng/mL for HMMA were still detected at 24 h. Urine tested positive by GC-MS for MDMA and HMMA in the 48-h collection period. These findings preliminarily support sweat testing with Drugwipe for monitoring MDMA use.  (+info)

Protein requirements of men in a hot climate: decreased urinary nitrogen losses concomitant with increased sweat nitrogen losses during exposure to high environmental temperature. (23/304)

In two separate experiments 8 healthy young men were given an egg-milk formula at a level of 0.7 g protein/kg per day, and were exposed to high environmental temperature (34--37 C, 7 hours daily) or cool temperature (21--26 C, all day), alternately. In the first experiment a 16-day hot period was followed by a 20-day cool period and finally by a 20-day hot period. Daily urinary nitrogen (N) loss of the last 8 days of cool period, 82.2 mg/kg, was significantly higher than that of the last 8 days of the 20-day hot period 69.7 mg/kg. Daily skin N loss was significantly lower during the last 8 days of the cool period (3.5 mg/kg) than during the last 8 days of the 20-day hot period (11.9 mg/kg). Urinary N and skin N lossess were negatively correlated (r equal to -0.905) in these periods. In the second experiment a 28 day hot period was followed by a 20-day cool period. Skin N loss diminished from 12.3 mg/kg daily during the last 12 days of the 28-day hot period to 4.1 mg/kg during the last 12-days of the cool period. At the same time, urinary N loss increased significantly from 81.4 mg/kg during the 28-day hot period to 95.2 mg/kg during a cool period. Urinary N and skin N losses were again negatively correlated (r equal to -0.620) during these periods. Results of these studies indicate that when skin N loss increases during high temperature, urinary N loss decreases gradually, but total N loss does not increase.  (+info)

Evaluation of immunoassays for semiquantitative detection of cocaine and metabolites or heroin and metabolites in extracts of sweat patches. (24/304)

Two types of immunoassays, radioimmunoassay (RIA) and microplate enzyme immunoassay (EIA), were compared for their ability to detect and quantitate cocaine and metabolites or heroin and metabolites in extracts of sweat patches. Experiments used sweat patches that had been fortified with cocaine, benzoylecgonine (BE), and ecgonine methyl ester (EME) or 6-acetylmorphine (6-AM), heroin, and morphine. Assays were first evaluated for sensitivity in detection of the analyte(s) known to be excreted in sweat (cocaine >> BE and EME; 6-AM > heroin > morphine). The cocaine metabolite RIA had cross-reactivity for cocaine > BE > EME, and the cocaine metabolite EIA had cross-reactivity for BE > cocaine >> EME. The RIA, having greater sensitivity for COC, was studied further. Optimal linearity was 4 to 200 ng/patch, and quantitation within these limits at 4, 75, and 150 ng/patch had intrarun %CVs within 7.8% and percent targets within 15% and inter-run %CVs within 13.5% and % targets within 13%. The opiate RIA had cross-reactivities for morphine >> 6-AM and heroin. The opiate EIA had cross-reactivities for 6-AM and heroin of 42 and 28% relative to morphine, respectively. The EIA, having greater sensitivity for 6-AM and heroin, was studied further. The limits of detection ranged from 1.7 to 24.7 ng/patch, and the lower limits of quantitation ranged from 7.3 ng/patch to beyond the linear range. The assay, however, had consistently good precision at 4 and 5 ng/patch, and optimal linearity was established from 4 to 100 ng/patch. With controls at 5, 25, and 90 ng/patch, both intrarun and inter-run precision were acceptable. Quantitation was accurate at 5 and 25 ng/patch, but the 90 ng/patch controls were consistently < 70% of target. Because our studies focused on the assays that had greater sensitivity for the analytes excreted in sweat, we did not fully evaluate the cocaine metabolite EIA or the RIA opiate screen and therefore cannot make any comment on the usefulness of these assays for detecting analytes in extracts of sweat patches beyond predicting that they will have less sensitivity. Both the cocaine metabolite RIA and opiate EIA had the ability to detect analytes known to be extracted from sweat patches.  (+info)